SCHEMBL5658867

SCHEMBL5658867

CC(C)(C)c1ccc(CNC(=O)Nc2cccc3ncccc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
PABPC1 P11940 2/20 0.69
EIF4H Q15056 2/20 0.69
TRPV1 Q8NER1 7/20 0.66
HDAC6 Q9UBN7 3/20 0.54
HDAC3 O15379 2/20 0.54
HDAC1 Q13547 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC4 P56524 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
NCOR2 Q9Y618 1/20 0.54
ALDH1A1 P00352 3/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
LMNA P02545 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5659936 0.86 TRPV1 (0.67) MEN1KMT2APABPC1EIF4HTRPV1
SCHEMBL13675975 0.83 MEN1 (0.67) MEN1KMT2APABPC1EIF4HTRPV1
SCHEMBL13762083 0.82 MEN1 (1.00) MEN1KMT2APABPC1EIF4HHDAC6
SCHEMBL5658523 0.81 TRPV1 (0.68) MEN1KMT2ATRPV1ALDH1A1SMN1; SMN2
SCHEMBL14860057 0.81 TRPV1 (0.65) MEN1KMT2ATRPV1ALDH1A1LMNA
SCHEMBL4019245 0.80 TRPV1 (1.00) TRPV1
SCHEMBL5657888 0.80 TRPV1 (0.84) MEN1KMT2ATRPV1HDAC6ALDH1A1
SCHEMBL4022819 0.78 TRPV1 (0.70) MEN1KMT2ATRPV1ALDH1A1KDM4E
SCHEMBL27599336 0.78 MEN1 (0.76) MEN1KMT2APABPC1EIF4HTRPV1
SCHEMBL4028233 0.77 TRPV1 (0.64) MEN1KMT2ATRPV1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285563-B2 Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2007-10-23 US disclosed
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain ARRB1, OPRL1, CNR1 MEN1 4770/4885KMT2A 4465/4885PABPC1 3181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.